Lv0
0 积分 2023-12-12 加入
[Consensus on immunohistochemical detection of PD-L1 (SP263) in bladder invasive urothelial carcinoma]
20小时前
已完结
[Expert consensus on PD-L1 expression testing in esophageal carcinoma in China]
1天前
已完结
Two Germline Pathogenic Variants in Cancer Susceptibility Genes and Their Null Implication in Breast Cancer Pathogenesis: The Importance of Tumoral Homologous Recombination Deficiency Testing
7个月前
已完结
CNS Antitumor Activity of Amivantamab With Osimertinib in Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer With Acquired Mesenchymal-Epithelial Transition Amplification Resistance Mechanism: A Case Report
7个月前
已完结
The PARTNER trial of neoadjuvant olaparib in triple-negative breast cancer
7个月前
已完结
中国髓母细胞瘤整合诊治指南
9个月前
已完结
肝癌新辅助治疗中国专家共识（2023版）
10个月前
已完结
肝癌新辅助治疗中国专家共识（2023版）
10个月前
已关闭
Near-Complete Pathological Response to Abemaciclib in the Treatment of Well-Differentiated/Dedifferentiated Liposarcoma: A Case Report. Near-Complete Pathological Response to Abemaciclib in the Treatment of Well-Differentiated/Dedifferentiated Liposarcoma: A Case Report
11个月前
已完结
EML4-ALK Variant 3a/b as a mechanism of osimertinib resistance in a patient with EGFR L858R positive NSCLC
11个月前
已完结
皖公网安备34019202002308
